首页> 外文期刊>Генетика: Ежемес. журн. >Predicting a clinical/biochemical phenotype for PKU/MHP patients with PAH gene mutations
【24h】

Predicting a clinical/biochemical phenotype for PKU/MHP patients with PAH gene mutations

机译:预测临床/生化表型北大/ MHP PAH基因突变的患者

获取原文
获取原文并翻译 | 示例
       

摘要

Phenylketonuria (PKU) and mild hyperphenylalaninemia (MHP) are allelic disorders caused by mutations in the gene encoding phenylalanine hydroxylase (PAH). In this study, a total of 218 independent PAH chromosomes (109 unrelated patients with PKU residing in Lithuania) were investigated. All 13 exons of the PAH gene of all PKU probands were scanned for DNA alterations by denaturing gradient gel electrophoresis (DGGE). In the cases of a specific DGGE pattern recognised, mutations were identified by direct fluorescent automated sequencing or by restriction enzyme digestion analysis of a relevant exons. 25 different PAH gene mutations were identified in Lithuania. We estimated a connection between individual PAH locus mutations and biochemical and metabolic phenotypes in patients in whom the mutant allele acts on its own, i.e., in functionally hemizygous patients and using the assigned value (AV) method to determine the severity of both common and rare mutant alleles, as well as to check a model to predict the combined phenotypic effect of two mutant PAH alleles.
机译:苯丙酮尿症(北大)和温和hyperphenylalaninemia (MHP)等位基因的失调引起的突变基因编码苯丙氨酸羟化酶(PAH)。共有218个独立的多环芳烃染色体(109北大驻留在患者无关立陶宛)进行调查。PAH基因DNA的所有北大渊源者都被扫描改变通过变性梯度凝胶电泳(DGGE)。具体的DGGE模式认可,突变通过直接荧光识别自动化测序或限制性内切酶消化分析相关的外显子。基因突变被确定在立陶宛。估计个人多环芳烃之间的连接位点突变和生化和代谢患者表型突变等位基因的人作用于自身,即在功能半合病人和使用指定的值(AV)方法确定常见和罕见的严重程度突变的等位基因,以及检查模型预测结合表型效应两种PAH突变等位基因。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号